Secretory clusterin (sCLU) overexpression is associated with resistance to preoperative neoadjuvant chemotherapy in primary breast cancer.Niu Zh, Liusheng Wu, Y Wang et al.|PubMed|2013Cited by 30
Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancerBrie Chun, David B. Page|Journal for ImmunoTherapy of Cancer|2022Cited by 18